{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-426828","form_type":"8-K","ticker":"SRZN","cik":"0001824893","company_name":"Surrozen, Inc./DE","filed_at":"2026-10-20T21:04:33+00:00","discovered_at":"2026-10-20T21:06:00.289871+00:00","generated_at":"2026-10-20T21:06:03.463321+00:00","sec_items":["2.02","3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Surrozen closes $95.1M second tranche at $11.60/share; cash runway extended into 2029","bullets":["Gross proceeds of ~$95.1M: 5,741,605 shares at $11.60, 2,456,500 pre-funded warrants at $11.5999, and Series E warrants for 4,099,052 shares at $11.54 strike.","Second closing milestone triggered by FDA clearance of the SZN-8141 IND on October 2, 2026, under the March 24, 2025 securities purchase agreement.","Post-closing capitalization: ~17.8M common shares outstanding, 3.8M issuable on pre-funded warrants, 9.1M on common warrants (mostly $11.54 strike, expiring 2029-2031).","Cash, equivalents and marketable securities expected to fund runway into 2029, including the DUET Phase 1b/2a study of SZN-8141 and initial Phase 1b development of SZN-8143.","Must file a resale S-3 within 30 days of closing and seek effectiveness within 90 days (120 if full SEC review)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-426828","json":"https://secwatch.observer/filing/0001193125-26-426828.json","markdown":"https://secwatch.observer/filing/0001193125-26-426828.md","text":"https://secwatch.observer/filing/0001193125-26-426828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526426828/0001193125-26-426828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824893/000119312526426828/srzn-20261020.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-20T21:06:03.463321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}